Phase I/II study to find the maximum tolerable dose of the combination of capecitabine and oral cyclophosphamide in the treatment of advanced cancer
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Capecitabine (Primary) ; Cyclophosphamide (Primary)
- Indications Cancer
- Focus Adverse reactions
- Acronyms Cyclox I
- Sponsors Roche
- 22 Jun 2016 New trial record